[Immunosuppressive therapy in severe or chronic pediatric uveitis: Review of the literature]

Abstract

Immunosuppressants are prescribed for pediatric uveitis in cases of severe involvement affecting the prognosis for vision or life, in cases of recurrent or chronic uveitis to achieve corticosteroid sparing, or in cases of corticosteroid resistance. Immunosuppressants used in children include antimetabolites (methotrexate, mycophenolate mofetil, azathioprine), cyclosporine, tacrolimus, and biologics, including infliximab, adalimumab, anakinra, canakinumab, and tocilizumab. The mechanisms of action and indications of the various immunosuppressants are described in this review.

Keywords: Anti-TNF; Azathioprine; Biologics; Biothérapies; Cyclosporine; Immunosuppressants; Immunosuppresseurs; Immunosuppressive therapy; Indications; Inflammation; Mechanisms of action; Methotrexate; Mycophenolate mofetil; Mécanismes d’action; Méthotrexate; Pediatric uveitis; Traitement immunosuppresseur; Uvéites pédiatriques.